Skip to main content
Premium Trial:

Request an Annual Quote

Genewiz, BeiGene Collaborate on Cancer Biomarker Discovery

NEW YORK (GenomeWeb News) – Genewiz today announced a deal with BeiGene for the use of Genewiz's cancer panels to accelerate cancer biomarker discovery.

Under the terms of the deal, Beijing-based BeiGene will use Genewiz's OncoGxOne Discovery cancer panels to identify and elucidate genetic variations in cancers that are prevalent in China and the Asia-Pacific region.

Financial and other terms of the deal were not disclosed.

"Our collaboration with Genewiz and application of the OncoGxOne(TM) cancer panels will enable characterization of primary tumor models at the genetic level, with a focus on aberrations in cancer related genes," Lai Wang, head of Discovery Biomarkers for BeiGene, said in a statement. BeiGene is a life science biotech firm focused on developing oncology drugs.

The deal is the second by South Plainfield, N.J.-based Genewiz in recent weeks aimed at the Chinese market. In late June it and KeyTest Diagnostics announced a collaboration to develop molecular diagnostics for that market.

Also, Genewiz and the John Theurer Cancer Center at Hackensack University Medical Center last month said they were collaborating on discovering ovarian cancer biomarkers.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.